Curi RMB Capital’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-10,287	Closed	-$1.17M	–	473
2021 Q1	$1.17M	Sell	10,287 -18,402	-64%	-$2.51M	0.04%	243
2020 Q4	$3.97M	Buy	28,689 +546	+2%	+$64.8K	0.15%	146
2020 Q3	$2.31M	Buy	28,143 +1,459	+5%	+$121K	0.1%	178
2020 Q2	$2.09M	Sell	26,684 -3,070	-10%	-$203K	0.09%	198
2020 Q1	$1.32M	Buy	29,754 +476	+2%	+$24.7K	0.06%	246
2019 Q4	$1.25M	Sell	29,278 -558	-2%	-$23K	0.03%	336
2019 Q3	$1.28M	Buy	29,836 +3,033	+11%	+$165K	0.03%	360
2019 Q2	$1.7M	Buy	26,803 +1,774	+7%	+$113K	0.04%	340
2019 Q1	$1.74M	Hold	25,029	–	–	0.04%	372
2018 Q4	$1.09M	Sell	25,029 -811	-3%	-$44.3K	0.03%	484
2018 Q3	$1.97M	Sell	25,840 -2,513	-9%	-$204K	0.05%	384
2018 Q2	$2.18M	Sell	28,353 -16,825	-37%	-$1.09M	0.05%	360
2018 Q1	$2.3M	Buy	45,178 +1,445	+3%	+$72.8K	0.06%	362
2017 Q4	$2.03M	Sell	43,733 -4,162	-9%	-$204K	0.05%	377
2017 Q3	$2.55M	Buy	47,895 +8,470	+21%	+$502K	0.07%	338
2017 Q2	$2.45M	Buy	+39,425	New	+$2.38M	0.07%	340